Mycosis fungoides causes: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 6: Line 6:
Development of cutaneous T cell lymphoma is the result of multiple [[Genetics|genetic]] [[mutation]]<nowiki/>s.
Development of cutaneous T cell lymphoma is the result of multiple [[Genetics|genetic]] [[mutation]]<nowiki/>s.
==Causes==
==Causes==
* The cause of Mycosis fungoides has not been identified.
* The cause of mycosis fungoides has not been identified. However, there are certain risk factors that predisposes to risk of mycosis fungoides.
* For more information on risk factors, [[Mycosis fungoides risk factors|click here]].
* Development of [[cutaneous T cell lymphoma]] is the result of multiple [[genetic mutations]].<ref name="ShinMonti2007">{{cite journal|last1=Shin|first1=J.|last2=Monti|first2=S.|last3=Aires|first3=D. J.|last4=Duvic|first4=M.|last5=Golub|first5=T.|last6=Jones|first6=D. A.|last7=Kupper|first7=T. S.|title=Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome|journal=Blood|volume=110|issue=8|year=2007|pages=3015–3027|issn=0006-4971|doi=10.1182/blood-2006-12-061507}}</ref><ref name="WongMishra2011">{{cite journal|last1=Wong|first1=Henry K.|last2=Mishra|first2=Anjali|last3=Hake|first3=Timothy|last4=Porcu|first4=Pierluigi|title=Evolving Insights in the Pathogenesis and Therapy of Cutaneous T-cell lymphoma (Mycosis Fungoides and Sezary Syndrome)|journal=British Journal of Haematology|volume=155|issue=2|year=2011|pages=150–166|issn=00071048|doi=10.1111/j.1365-2141.2011.08852.x}}</ref><ref name="Wilcox2011">{{cite journal|last1=Wilcox|first1=Ryan A.|title=Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management|journal=American Journal of Hematology|volume=86|issue=11|year=2011|pages=928–948|issn=03618609|doi=10.1002/ajh.22139}}</ref><ref name="Whittaker2006">{{cite journal|last1=Whittaker|first1=Sean|title=Biological Insights into the Pathogenesis of Cutaneous T-Cell Lymphomas (CTCL)|journal=Seminars in Oncology|volume=33|year=2006|pages=3–6|issn=00937754|doi=10.1053/j.seminoncol.2005.12.015}}</ref><ref>{{Cite journal
* Development of [[cutaneous T cell lymphoma]] is the result of multiple [[genetic mutations]].<ref name="ShinMonti2007">{{cite journal|last1=Shin|first1=J.|last2=Monti|first2=S.|last3=Aires|first3=D. J.|last4=Duvic|first4=M.|last5=Golub|first5=T.|last6=Jones|first6=D. A.|last7=Kupper|first7=T. S.|title=Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome|journal=Blood|volume=110|issue=8|year=2007|pages=3015–3027|issn=0006-4971|doi=10.1182/blood-2006-12-061507}}</ref><ref name="WongMishra2011">{{cite journal|last1=Wong|first1=Henry K.|last2=Mishra|first2=Anjali|last3=Hake|first3=Timothy|last4=Porcu|first4=Pierluigi|title=Evolving Insights in the Pathogenesis and Therapy of Cutaneous T-cell lymphoma (Mycosis Fungoides and Sezary Syndrome)|journal=British Journal of Haematology|volume=155|issue=2|year=2011|pages=150–166|issn=00071048|doi=10.1111/j.1365-2141.2011.08852.x}}</ref><ref name="Wilcox2011">{{cite journal|last1=Wilcox|first1=Ryan A.|title=Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management|journal=American Journal of Hematology|volume=86|issue=11|year=2011|pages=928–948|issn=03618609|doi=10.1002/ajh.22139}}</ref><ref name="Whittaker2006">{{cite journal|last1=Whittaker|first1=Sean|title=Biological Insights into the Pathogenesis of Cutaneous T-Cell Lymphomas (CTCL)|journal=Seminars in Oncology|volume=33|year=2006|pages=3–6|issn=00937754|doi=10.1053/j.seminoncol.2005.12.015}}</ref><ref>{{Cite journal
  | author = [[Henry K. Wong]]
  | author = [[Henry K. Wong]]

Revision as of 20:06, 28 January 2019

Mycosis fungoides Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mycosis Fungoides from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

CT Scan

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mycosis fungoides causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mycosis fungoides causes

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mycosis fungoides causes

CDC on Mycosis fungoides causes

Mycosis fungoides causes in the news

Blogs on Mycosis fungoides causes

Directions to Hospitals Treating Mycosis fungoides

Risk calculators and risk factors for Mycosis fungoides causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2], Sogand Goudarzi, MD [3]

Overview

Development of cutaneous T cell lymphoma is the result of multiple genetic mutations.

Causes


References

  1. Shin, J.; Monti, S.; Aires, D. J.; Duvic, M.; Golub, T.; Jones, D. A.; Kupper, T. S. (2007). "Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome". Blood. 110 (8): 3015–3027. doi:10.1182/blood-2006-12-061507. ISSN 0006-4971.
  2. Wong, Henry K.; Mishra, Anjali; Hake, Timothy; Porcu, Pierluigi (2011). "Evolving Insights in the Pathogenesis and Therapy of Cutaneous T-cell lymphoma (Mycosis Fungoides and Sezary Syndrome)". British Journal of Haematology. 155 (2): 150–166. doi:10.1111/j.1365-2141.2011.08852.x. ISSN 0007-1048.
  3. Wilcox, Ryan A. (2011). "Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management". American Journal of Hematology. 86 (11): 928–948. doi:10.1002/ajh.22139. ISSN 0361-8609.
  4. Whittaker, Sean (2006). "Biological Insights into the Pathogenesis of Cutaneous T-Cell Lymphomas (CTCL)". Seminars in Oncology. 33: 3–6. doi:10.1053/j.seminoncol.2005.12.015. ISSN 0093-7754.
  5. Henry K. Wong (2013). "Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma". Discovery medicine. 16 (87): 71–78. PMID 23998443. Unknown parameter |month= ignored (help)